| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |